Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort

References

• Karavitaki N, Cudlip S, Adams CB, et al. Craniopharyngiomas. Endocr Rev. 2006;27:371–397.
   PubMed Web of Science ®Google Scholar
• Trippel M, Nikkhah G. Stereotactic neurosurgical treatment options for craniopharyngioma. Front Endocrinol (Lausanne). 2012;3:63.
   PubMedGoogle Scholar
• Combs SE, Thilmann C, Huber PE, et al. Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer. 2007;109:2308–2314.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Frank C, Herfarth KK, et al. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2002;54:1114–1120.
   PubMed Web of Science ®Google Scholar
• Fahlbusch R, Honegger J, Paulus W, et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg. 1999;90:237–250.
   PubMed Web of Science ®Google Scholar
• Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg. 1990;73:3–11.
   PubMed Web of Science ®Google Scholar
• Elhateer H, Muanza T, Roberge D, et al. Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas. Curr Oncol. 2008;15:286–292.
   PubMed Web of Science ®Google Scholar
• Roug S, Rasmussen AK, Juhler M, et al. Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit. Eur J Endocrinol. 2010;162:685–694.
   PubMed Web of Science ®Google Scholar
• Nutting C, Brada M, Brazil L, et al. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg. 1999;90:823–827.
   PubMed Web of Science ®Google Scholar
• Kanesaka N, Mikami R, Nakayama H, et al. Preliminary results of fractionated stereotactic radiotherapy after cyst drainage for craniopharyngioma in adults. Int J Radiat Oncol Biol Phys. 2012;82:1356–1360.
   PubMed Web of Science ®Google Scholar
• Hashizume C, Mori Y, Kobayashi T, et al. Stereotactic radiotherapy using Novalis for craniopharyngioma adjacent to optic pathways. J Neurooncol. 2010;98:239–247.
   PubMed Web of Science ®Google Scholar
• Selch MT, DeSalles AA, Wade M, et al. Initial clinical results of stereotactic radiotherapy for the treatment of craniopharyngiomas. Technol Cancer Res Treat. 2002;1:51–59.
   PubMed Web of Science ®Google Scholar
• Minniti G, Saran F, Traish D, et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol. 2007;82:90–95.
   PubMed Web of Science ®Google Scholar
• Harrabi SB, Adeberg S, Welzel T, et al. Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects. Radiat Oncol. 2014;9:203.
   PubMed Web of Science ®Google Scholar
• Bishop AJ, Greenfield B, Mahajan A, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014;90:354–361.
   PubMed Web of Science ®Google Scholar
• Astradsson A, Wiencke AK, Munck af Rosenschold P, et al. Visual outcome after fractionated stereotactic radiation therapy of benign anterior skull base tumors. J Neurooncol. 2014;118:101–108.
   PubMed Web of Science ®Google Scholar
• Klose M, Stochholm K, Janukonyte J, et al. Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism. J Clin Endocrinol Metab. 2014;99:101–110.
   PubMed Web of Science ®Google Scholar
• Klose M, Lange M, Rasmussen AK, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab. 2007;92:1326–1333.
   PubMed Web of Science ®Google Scholar
• Littley MD, Shalet SM, Beardwell CG, et al. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med. 1989;70:145–160.
   PubMedGoogle Scholar
• Inoue HK, Nakamura M, Ono N, et al. Radiosensitive squamous cell craniopharyngioma: clinical and pathological comparison with the adamantinomatous type. Noshuyo Byori. 1993;10:27–31.
   PubMedGoogle Scholar
• Sartoretti-Schefer S, Wichmann W, Aguzzi A, et al. MR differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR Am J Neuroradiol. 1997;18:77–87.
   PubMed Web of Science ®Google Scholar
• Chiou SM, Lunsford LD, Niranjan A, et al. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro-oncology. 2001;3:159–166.
   PubMed Web of Science ®Google Scholar
• Chung WY, Pan DH, Shiau CY, et al. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg. 2000;93(Suppl 3):47–56.
   PubMed Web of Science ®Google Scholar
• Leber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998;88:43–50.
   PubMed Web of Science ®Google Scholar
• Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002;97:3–11.
   PubMed Web of Science ®Google Scholar
• Niranjan A, Kano H, Mathieu D, et al. Radiosurgery for craniopharyngioma. Int J Radiat Oncol Biol Phys. 2010;78:64–71.
   PubMed Web of Science ®Google Scholar
• Ulfarsson E, Lindquist C, Roberts M, et al. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg. 2002;97:613–622.
   PubMed Web of Science ®Google Scholar